Subscribe To
Nexcella, immix biopharma subsidiary, to present at the bank of america 2023 healthcare trailblazers private company conference
LOS ANGELES, Sept. 07, 2023 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”) a clinical...
September 7, 2023, 12:41 pm
Affimed to present at the h.c. wainwright annual global investment conference
HEIDELBERG, Germany, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-o...
September 7, 2023, 6:30 am
Bragar eagel & squire, p.c. reminds investors that class action lawsuits have been filed against baxter, rain, and danaher, and encourages investors to contact the firm
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...
September 7, 2023, 1:00 am
Merck & co., inc. (mrk) citi 18th annual biopharma conference (transcript)
Merck & Co., Inc. (NYSE:MRK ) Citi 18th Annual BioPharma Conference September 6, 2023 1:50 PM ET Company Participants Marjorie Green - SVP and Head of...
September 6, 2023, 6:40 pm
Increase access to life saving cancer treatment with accarent health’s oncology and gene therapy bundles
While almost 2 million new cancer cases are expected to be diagnosed in the US this year, cancer death rates have fallen 33% due to advances in treatm...
September 6, 2023, 1:54 pm
Harpoon therapeutics abstract for hpn217 accepted for poster presentation at the 20th international myeloma society annual meeting
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-...
September 6, 2023, 11:30 am
Amgen (amgn) stock outperforms industry ytd: here's why
Amgen (AMGN) expects strong sales growth of products like Tezspire, Evenity and Repatha to be offset by lower revenues from ...
September 6, 2023, 11:18 am
Lava therapeutics to participate in the h.c. wainwright 25th annual global investment conference
UTRECHT, The Netherlands and PHILADELPHIA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. ( Nasdaq: LVTX ), an immuno-...
September 6, 2023, 7:11 am
Genenta to present at upcoming scientific and investor conferences
MILAN, Italy and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (NASDAQ: GNTA) a clinical-stage immuno-...
September 6, 2023, 7:00 am
Medigene ag to present at the h.c. wainwright 25th annual global investment conference
Planegg/Martinsried, September 5, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology<...
September 5, 2023, 11:00 am
Pfizer invites public to view and listen to webcast of pfizer discussion at healthcare conference
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Angel...
September 5, 2023, 10:00 am
Harpoon therapeutics to host kol event in person and via webcast on september 15, 2023
KOLs to provide insight and discussion of HPN328 targeting SCLC, NEPC and other neuroendocrine tumors Abstract with HPN328 interim data accepted for p...
September 5, 2023, 8:05 am
Angle unveils groundbreaking cancer diagnostic tool
ANGLE plc, a frontrunner in liquid biopsy technology, has unveiled its latest innovation, the Portrait Flex CTC assay - a cutting-edge diagnostic tool...
September 4, 2023, 3:09 am
Abbvie: balance is everything
AbbVie's future growth depends on improving its balance of drugs offered, in contrast to its Humira-dependent first decade. Skyrizi and Rinvoq should ...
September 4, 2023, 1:12 am
3 reasons to buy pfizer stock
Pfizer is currently pumping out plenty of brand-new approvals this year. The company's latest acquisition should strengthen its ...
September 3, 2023, 8:30 am
Lifshitz law pllc announces investigations of rain oncology, inc. (nasdaq: rain), danaher corp. (nyse: dhr), bausch health companies, inc. (nyse: bhc), and at&t inc. (nyse: t)
NEW YORK, Sept. 02, 2023 (GLOBE NEWSWIRE) — Rain oncology, Inc. (NASDAQ: RAIN) Lifshitz Law PLLC anno...
September 2, 2023, 11:00 pm
Bragar eagel & squire, p.c. reminds investors that class action lawsuits have been filed against seagate, baxter, and rain and encourages investors to contact the firm
NEW YORK, Sept. 01, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...
September 2, 2023, 1:00 am
Biontech: not just another jab in the arm
BioNTech's Q2 2023 revenues significantly decreased due to declining COVID-19 vaccine sales, but the company holds $15.3B in cash reserves. The compan...
September 1, 2023, 5:13 pm
Biomea fusion announces appointment of juan pablo frías, m.d. as chief medical officer
Industry veteran and prominent diabetes clinical development expert to oversee Biomea’s progressing clinical development of novel covalent menin inh...
August 31, 2023, 12:30 pm
Rosen, global investor counsel, encourages rain oncology inc. investors with losses in excess of $100k to secure counsel before important september 12 deadline in securities class action – rain
NEW YORK, Aug. 31, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain ...
August 31, 2023, 1:16 am